DV
Dividend Vision

PHR Stock — Phreesia, Inc.

Phreesia, Inc. (PHR)

Updated October 16, 2026.

PHR is a Stock. Total return is -56.4% over the past 7.2 years, 240.0 points behind SPY at 183.6%.

Phreesia, Inc. is a healthcare software company that provides a cloud-based platform delivering patient intake, appointment management, payment processing, and clinical data capture solutions to ambulatory practices, health systems, hospitals, and life sciences organizations across the United States and Canada. The company does not currently distribute dividends to shareholders. This equity security appeals to investors seeking exposure to healthcare technology and software-as-a-service businesses rather than income-focused investors.

PHR performance versus SPY

Price and return data through 2026-10-16.

Total return is -56.4% over the past 7.2 years, 240.0 points behind SPY at 183.6%. Over the past year its total return — price change plus distributions reinvested — is -51.9%. Its deepest 1-year drawdown was 65.7%.

WindowTotal returnCAGR
1M6.8%—
3M0.5%—
6M19.3%—
YTD-35.3%—
1Y-51.9%—
2Y CAGR—-27.60%
3Y CAGR—-12.60%
5Y CAGR—-29.70%
Since inception (7.2 years)-56.4%-10.80%

PHR key facts

Asset type
Stock
Asset class
Equity
Inception date
07/18/2019
Distribution frequency
None
Last close
$10.94 (as of 2026-10-16)
Market cap
$679,056,127
Average volume
655027.0
Beta
0.843
Payout ratio
0.0%
P/E ratio
64.35
Forward P/E
12.0192
EPS
$0.17

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PHR risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 65.7%.

Who may consider PHR — and who may not

It is a weaker fit for investors who need monthly cash flow (PHR does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PHR

Tagged: Healthcare.

Frequently asked questions

Does PHR pay monthly?

No. PHR does not currently distribute.

When does PHR pay a dividend?

PHR does not currently distribute.

How has PHR performed?

Total return is -56.4% over the past 7.2 years, 240.0 points behind SPY at 183.6%. Over the past year its total return — price change plus distributions reinvested — is -51.9%. Its deepest 1-year drawdown was 65.7%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.